BRIEF-Kelly Enters Agreement To Acquire Specialty Talent Solutions Company-March 2024-www.financetom.com

BRIEF-Kelly Enters Agreement To Acquire Specialty Talent Solutions Company

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Kelly Enters Agreement To Acquire Specialty Talent Solutions Company

May 3, 2024 5:30 AM

May 3 (Reuters) - Kelly Services Inc ( KELYA ):

* KELLY ENTERS AGREEMENT TO ACQUIRE SPECIALTY TALENT

SOLUTIONS

COMPANY, MOTION RECRUITMENT PARTNERS, LLC

* KELLY SERVICES INC ( KELYA ) - UNDER TERMS OF AGREEMENT, KELLY WILL

ACQUIRE MRP FOR $425 MILLION IN CASH

* KELLY SERVICES INC ( KELYA ) - EXPECTS TO FUND TRANSACTION THROUGH

DEBT

AND AVAILABLE CAPITAL

* KELLY SERVICES INC ( KELYA ) - EARNOUT POTENTIAL UP TO $60 MILLION

FOR

KELLY

Source text for Eikon:

Further company coverage:

Previous page： Top Premarket Decliners Next page： Arch Biopartners Says St. Michael's Hospital Joins Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-AKI

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Top Premarket Decliners

Apr 16, 2024

08:09 AM EDT, 04/16/2024 (MT Newswires) -- Ryvyl ( RVYL ) shares fell 39% after the company said it has launched a public offering of shares. Skillsoft Corp. ( SKIL ) shares dropped 20% after the company posted lower fiscal Q4 revenue. Inovio Pharmaceuticals ( INO ) shares retreated 24% after the company launched a $36 million underwritten offering of...

Arch Biopartners Says St. Michael's Hospital Joins Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-AKI

Apr 16, 2024

08:14 AM EDT, 04/16/2024 (MT Newswires) -- Arch Biopartners Inc. ( ACHFF ) on Tuesday said a research team from St. Michael's Hospital, a site of Unity Health Toronto, has joined the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). LSALT peptide is Arch's lead candidate for preventing and treating...

GSK Says US FDA Accepts Meningococcal Vaccine Candidate for Regulatory Review

Apr 16, 2024

08:14 AM EDT, 04/16/2024 (MT Newswires) -- GSK (GSK) said in a regulatory filing Tuesday that the US Food and Drug Administration has accepted for review the company's biologics license application for its meningococcal ABCWY vaccine candidate. The pharmaceutical giant said the vaccine candidate provides broad coverage against the five most common groups of bacteria causing invasive meningococcal disease, and...

Bain proposes Japan's Kioxia IPO to clear $5.8 bln loan refinance

Apr 16, 2024

TOKYO, April 16 (Reuters) - Bain Capital has proposed an initial public offering (IPO) of Japan's Kioxia Holdings as part of a plan to allow the money-losing chipmaker to refinance a $5.8 billion loan coming due in June, according to a person familiar with the matter. Bain and Kioxia met with a group of banks including Sumitomo Mitsui, Mizuho and...